We have located links that may give you full text access.
Extended criteria donor lung reconditioning with the organ care system lung: A single institution experience.
Transplant International 2018 October 24
OBJECTIVE: Lung transplantation is a life-saving procedure limited by donor's availability. Lung reconditioning by Ex Vivo Lung Perfusion represents a tool to expand the donor pool. In this study, we describe our experience with the OCS™ Lung to assess and recondition extended criteria lungs.
METHODS: From January 2014 to October 2016, out of 86 on-site donors evaluated, 8 lungs have been identified as potentially treatable with OCS™ Lung. We analyzed data from these donors and the recipient outcomes after transplantation.
RESULTS: All donor lungs improved during OCS perfusion in particular regarding the PaO2 /FiO2 ratio (from 340 mmHg in donor to 537 mmHg in OCS) leading to lung transplantation in all cases. Concerning post-operative results, PGD score 3 at 72 hours was observed in one patient, while median mechanical ventilation time, ICU and hospital stay were 60 hours, 14 and 36 days, respectively. One in-hospital death was recorded (12.5%), while other two patients died during follow-up leading to 1-year survival of 62.5%. The remaining 5 patients are alive and in good conditions.
CONCLUSION: This case series demonstrates the feasibility and value of lung reconditioning with the OCS™ Lung; a prospective trial is underway to validate its role to safely increase the number of donor lungs. This article is protected by copyright. All rights reserved.
METHODS: From January 2014 to October 2016, out of 86 on-site donors evaluated, 8 lungs have been identified as potentially treatable with OCS™ Lung. We analyzed data from these donors and the recipient outcomes after transplantation.
RESULTS: All donor lungs improved during OCS perfusion in particular regarding the PaO2 /FiO2 ratio (from 340 mmHg in donor to 537 mmHg in OCS) leading to lung transplantation in all cases. Concerning post-operative results, PGD score 3 at 72 hours was observed in one patient, while median mechanical ventilation time, ICU and hospital stay were 60 hours, 14 and 36 days, respectively. One in-hospital death was recorded (12.5%), while other two patients died during follow-up leading to 1-year survival of 62.5%. The remaining 5 patients are alive and in good conditions.
CONCLUSION: This case series demonstrates the feasibility and value of lung reconditioning with the OCS™ Lung; a prospective trial is underway to validate its role to safely increase the number of donor lungs. This article is protected by copyright. All rights reserved.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app